BCYC
Price
$7.13
Change
+$0.26 (+3.78%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
488.35M
90 days until earnings call
Intraday BUY SELL Signals
NRIX
Price
$16.83
Change
+$0.48 (+2.94%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
1.72B
76 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BCYC vs NRIX

Header iconBCYC vs NRIX Comparison
Open Charts BCYC vs NRIXBanner chart's image
Bicycle Therapeutics
Price$7.13
Change+$0.26 (+3.78%)
Volume$1.62K
Capitalization488.35M
Nurix Therapeutics
Price$16.83
Change+$0.48 (+2.94%)
Volume$32.27K
Capitalization1.72B
BCYC vs NRIX Comparison Chart in %
BCYC
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BCYC vs. NRIX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Hold and NRIX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (BCYC: $6.87 vs. NRIX: $16.35)
Brand notoriety: BCYC and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 50% vs. NRIX: 52%
Market capitalization -- BCYC: $488.35M vs. NRIX: $1.72B
BCYC [@Biotechnology] is valued at $488.35M. NRIX’s [@Biotechnology] market capitalization is $1.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileNRIX’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • NRIX’s FA Score: 0 green, 5 red.
According to our system of comparison, NRIX is a better buy in the long-term than BCYC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 4 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • BCYC’s TA Score: 4 bullish, 6 bearish.
  • NRIX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NRIX is a better buy in the short-term than BCYC.

Price Growth

BCYC (@Biotechnology) experienced а 0.00% price change this week, while NRIX (@Biotechnology) price change was -3.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

BCYC is expected to report earnings on Mar 03, 2026.

NRIX is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($1.72B) has a higher market cap than BCYC($488M). NRIX YTD gains are higher at: -13.217 vs. BCYC (-50.929). BCYC (-240.81M) and NRIX (-248.7M) have comparable annual earnings (EBITDA) . BCYC has more cash in the bank: 721M vs. NRIX (429M). BCYC has less debt than NRIX: BCYC (7.2M) vs NRIX (56.5M). NRIX has higher revenues than BCYC: NRIX (83.7M) vs BCYC (19.3M).
BCYCNRIXBCYC / NRIX
Capitalization488M1.72B28%
EBITDA-240.81M-248.7M97%
Gain YTD-50.929-13.217385%
P/E RatioN/AN/A-
Revenue19.3M83.7M23%
Total Cash721M429M168%
Total Debt7.2M56.5M13%
FUNDAMENTALS RATINGS
BCYC: Fundamental Ratings
BCYC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYCNRIX
RSI
ODDS (%)
Bullish Trend 6 days ago
79%
Bearish Trend 6 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
87%
Bearish Trend 6 days ago
90%
Momentum
ODDS (%)
Bullish Trend 6 days ago
78%
Bullish Trend 6 days ago
81%
MACD
ODDS (%)
Bullish Trend 6 days ago
75%
Bullish Trend 6 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 6 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
86%
Bullish Trend 6 days ago
79%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 14 days ago
88%
Bearish Trend 16 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 6 days ago
85%
Aroon
ODDS (%)
Bearish Trend 6 days ago
84%
Bullish Trend 6 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
BCYC
Daily Signal:
Gain/Loss:
NRIX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PXINX12.86N/A
N/A
Impax International Sust Econ Inv
FERCX51.86N/A
N/A
Fidelity Advisor Emerging Asia C
ODINX93.52N/A
N/A
Invesco Discovery R
SSCCX0.40N/A
N/A
Saratoga Small Capitalization C
TICIX36.99N/A
N/A
Timothy Plan Israel Common Values I

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with RPTX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-2.41%
RPTX - BCYC
50%
Loosely correlated
-0.14%
INO - BCYC
46%
Loosely correlated
-0.52%
RGNX - BCYC
44%
Loosely correlated
-3.10%
NRIX - BCYC
44%
Loosely correlated
-3.31%
XNCR - BCYC
42%
Loosely correlated
-3.15%
More